Under construction – not a live service
Sign in
CompletedNo phase

Thyroid Uptake Quantification Validation on a Three-dimensional (3D) Cadmium-Zinc-Telluride (CZT) New Generation Gamma Camera

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

Trial details

Who runs it
Centre Hospitalier Princesse Grace
Trial code
NCT07610460
Record updated
28 May 2026
Original description
Thyroid scintigraphy using technetium-99m (99mTc) pertechnetate is traditionally performed using planar imaging to estimate thyroid uptake. Recent developments in quantitative SPECT/CT allow direct activity quantification from three-dimensional tomographic acquisitions. The aim of this study was to evaluate the accuracy of thyroid uptake quantification obtained from 3D SPECT/CT compared with conventional planar image.Read full original descriptionShow less

Clinical Evaluation of Thyroid Uptake Quantification With Technetium-99m (99mTc)-Pertechnetate: Comparison Between Gold Standard Planar and Quantitative 3D CZT Single Photon Emission Computed Tomography/Cumputed Tomography (SPECT/CT) Scintigraphy

Thyroid scintigraphy using technetium-99m (99mTc) pertechnetate is traditionally performed using planar imaging to estimate thyroid uptake. Recent developments in quantitative SPECT/CT allow direct activity quantification from three-dimensional tomographic acquisitions. The aim of this study was to evaluate the accuracy of thyroid uptake quantification obtained from 3D SPECT/CT compared with conventional planar image.

Inclusion: hypothyroidism; hyperthyroidism.

Exclusion: Pregnant women.

ClinicalTrials.gov NCT07610460